Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Shareholders??? Equity (Unaudited)

v3.21.1
Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Share
Preferred Shares
Additional Paid-in Capital
Retained Earnings/(Deficit)
Accumulated Deficit Other Comprehensive Income
Attributable to Non- controlling Interest
Total
Balance, at Dec. 31, 2018 $ 2 $ 22,117 $ 6,407 $ 1,191 $ 12,896 $ 42,613
Balance, (in Shares) at Dec. 31, 2018 19,221,609          
Retroactive application of recapitalization $ (2) 2
Retroactive application of recapitalization (in Shares) (12,901,544)          
Balance, at Dec. 31, 2018 22,119 6,407 1,191 12,896 42,613
Balance, (in Shares) at Dec. 31, 2018 6,320,065          
Conversion of Series C convertible debentures 22,364 22,364
Conversion of Series C convertible debentures (in Shares) 837,345          
Class C preferred stock issuance 28,824 28,824
Class C preferred stock issuance (in Shares) 1,131,824          
Stock-based compensation expenses 1,522 1,522
Stock option exercise 132 132
Stock option exercise (in Shares) 14,796          
Investment in subsidiaries 1,752 (1,752)
Issuance of Rock Cliff Capital warrants 717 717
Other comprehensive income 1,191 (1,191)    
Net loss (39,530) (6,450) (45,980) [1],[2]
Balance, at Dec. 31, 2019 77,431 (31,933) 4,695 50,193
Balance, (in Shares) at Dec. 31, 2019 8,304,030          
Balance, at Dec. 31, 2019 $ 2 $ 1 77,428 (31,933)   4,695 50,193
Balance, (in Shares) at Dec. 31, 2019 19,266,609 5,988,957          
Retroactive application of recapitalization $ (2) $ (1) 3  
Retroactive application of recapitalization (in Shares) (10,962,579) (5,988,957)          
Stock-based compensation expenses 416   416
Net loss (9,282)   (904) (10,186)
Balance, at Mar. 31, 2020 77,847 (41,215)   3,791 40,423
Balance, (in Shares) at Mar. 31, 2020 8,304,030            
Balance, at Dec. 31, 2019 $ 2 $ 1 77,428 (31,933)   4,695 50,193
Balance, (in Shares) at Dec. 31, 2019 19,266,609 5,988,957          
Retroactive application of recapitalization $ (2) $ (1) 3        
Retroactive application of recapitalization (in Shares) (10,962,579) (5,988,957)          
Balance, at Dec. 31, 2019 77,431 (31,933) 4,695 50,193
Balance, (in Shares) at Dec. 31, 2019 8,304,030          
Stock issuances, Class D preferred shares     18,087 18,087
Stock issuances, Class D preferred shares (in Shares) 2,574,374          
Stock-based compensation expenses 1,652 1,652
Purchase and cancellation of stock, Class C preferred shares (6,250) (6,250)
Purchase and cancellation of stock, Class C preferred shares (in Shares) (233,788)            
Stock option exercise 20 20
Stock option exercise (in Shares) 88,707            
Issuance of common shares upon vesting of RSUs
Issuance of common shares upon vesting of RSUs (in Shares) 2,989          
Net loss   (25,895)   (25,895) [3],[4],[5]
Share exchange      
Share exchange (in Shares) 717,085            
Conversion of Convertible Debentures 9,850 9,850
Conversion of Convertible Debentures (in Shares) 984,567            
Common shares issued for exercise of warrants 3 3
Common shares issued for exercise of warrants (in Shares) 300,000            
Conversion of the redeemable non-controlling interest 4,695 (4,695)
Conversion of the redeemable non-controlling interest (in Shares) 1,562,339            
Business combination and PIPE financing 47,794 47,794
Business combination and PIPE financing (in Shares) 10,582,721            
Accretion of Class D preferred shares to liquidation preference on automatic conversion 10,219 (10,219)
Reclassifications and other 763 (967) (204)
Balance, at Dec. 31, 2020 [5] [5] 164,264 (69,014) 95,250
Balance, (in Shares) at Dec. 31, 2020 [5] 24,883,024          
Stock-based compensation expenses 1,550       1,550
Issuance of common shares upon vesting of RSUs  
Issuance of common shares upon vesting of RSUs (in Shares) 7,713          
Founders earnout shares vested    
Founders earnout shares vested (in Shares) 570,212            
Net loss (13,765)   (13,765)
Common shares issued for exercise of warrants 1,410   1,410
Common shares issued for exercise of warrants (in Shares) 122,639            
Balance, at Mar. 31, 2021 $ 167,224 $ (82,779)   $ 84,445
Balance, (in Shares) at Mar. 31, 2021 25,583,588            
[1] Loss before income taxes of $45,884 plus loss from equity investment of $96.
[2] See Note 3. for information on the restatement adjustment as of December 31, 2020 and on the reclassification adjustment as of December 31, 2019.
[3] Following the SEC statement in April 2021, the Company determined that the private warrants should be classified as a liability. Refer to Note 3. for more information and the impact on the Company’s financial statements.
[4] Loss before income taxes of $25,891 plus loss from equity investment of $4.
[5] See Note 3. for information on the restatement adjustment as of December 31, 2020.